Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1952 1
1956 1
1958 1
1960 5
1961 3
1962 4
1963 8
1964 10
1965 13
1966 9
1967 10
1968 11
1969 11
1970 8
1971 15
1972 14
1973 9
1974 12
1975 16
1976 13
1977 23
1978 22
1979 19
1980 28
1981 30
1982 39
1983 38
1984 37
1985 40
1986 47
1987 41
1988 47
1989 56
1990 58
1991 76
1992 82
1993 77
1994 59
1995 74
1996 74
1997 93
1998 105
1999 71
2000 54
2001 63
2002 71
2003 89
2004 87
2005 70
2006 76
2007 99
2008 112
2009 122
2010 126
2011 149
2012 135
2013 148
2014 136
2015 133
2016 159
2017 182
2018 195
2019 176
2020 231
2021 247
2022 272
2023 248
2024 235
2025 248
2026 136

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,942 results

Results by year

Filters applied: . Clear all
Page 1
Cholinergic regulation of thymocyte negative selection.
Liu S, Zheng C, Nechanitzky R, Luo P, Ramachandran P, Nguyen D, Elia AJ, Moghadas Jafari S, Law R, Snow BE, Wakeham AC, Berger T, Chen H, Gill KT, Mcwilliam R, Fortin J, Modares NF, Saunders ME, Murakami K, Qiu Y, You Z, Mohtashami M, Qi H, Ohashi PS, Zúñiga-Pflücker JC, Mak TW. Liu S, et al. Among authors: murakami k. Nat Immunol. 2025 Jun;26(6):881-893. doi: 10.1038/s41590-025-02152-4. Epub 2025 May 21. Nat Immunol. 2025. PMID: 40399609
Tumor immunology and immunotherapy for endometrial cancer.
Murakami K, Takamura S, Kakimi K, Matsumura N. Murakami K, et al. Expert Opin Investig Drugs. 2025 Jan-Feb;34(1-2):37-48. doi: 10.1080/13543784.2025.2463091. Epub 2025 Feb 11. Expert Opin Investig Drugs. 2025. PMID: 39912523 Free article. Review.
AQP5: A functional gastric cancer stem cell marker in mouse and human tumors.
Lim HYG, Yada S, Murakami K, Lee BTK, Sagiraju S, Phuah P, Chen TC, Alvina FB, Tan SH, Kaslikar KK, Ruhazat NSB, Rajapakse MP, Murad KBA, Kancheva S, Tan LT, Mustafah S, So JBY, Barker N. Lim HYG, et al. Among authors: murakami k. Science. 2025 Dec 18;390(6779):eadr2428. doi: 10.1126/science.adr2428. Epub 2025 Dec 18. Science. 2025. PMID: 41411445
Japanese guidelines for treatment of pediatric status epilepticus - 2023.
Kikuchi K, Kuki I, Nishiyama M, Ueda Y, Matsuura R, Shiohama T, Nagase H, Akiyama T, Sugai K, Hayashi K, Murakami K, Yamamoto H, Fukuda T, Kashiwagi M, Maegaki Y. Kikuchi K, et al. Among authors: murakami k. Brain Dev. 2025 Feb;47(1):104306. doi: 10.1016/j.braindev.2024.104306. Epub 2024 Dec 2. Brain Dev. 2025. PMID: 39626562 Free article. Review.
Impaired Glycosylation of Gastric Mucins Drives Gastric Tumorigenesis and Serves as a Novel Therapeutic Target.
Arai J, Hayakawa Y, Tateno H, Murakami K, Hayashi T, Hata M, Matsushita Y, Kinoshita H, Abe S, Kurokawa K, Oya Y, Tsuboi M, Ihara S, Niikura R, Suzuki N, Iwata Y, Shiokawa T, Shiomi C, Uekura C, Yamamoto K, Fujiwara H, Kawamura S, Nakagawa H, Mizuno S, Kudo T, Takahashi S, Ushiku T, Hirata Y, Fujii C, Nakayama J, Shibata S, Woods S, Worthley DL, Hatakeyama M, Wang TC, Fujishiro M. Arai J, et al. Among authors: murakami k. Gastroenterology. 2024 Aug;167(3):505-521.e19. doi: 10.1053/j.gastro.2024.03.037. Epub 2024 Apr 6. Gastroenterology. 2024. PMID: 38583723 Free PMC article.
ARID1A mutation drives gastric tumorigenesis via activating type 2 immune dominant microenvironment.
Arai J, Hayakawa Y, Suzuki N, Kinoshita H, Hata M, Kurokawa K, Matsushita Y, Abe S, Oya Y, Tsuboi M, Ihara S, Iwata Y, Murakami K, Shiokawa T, Shiomi C, Uekura C, Yamamoto K, Fujiwara H, Kawamura S, Nakagawa H, Ikenoue T, Tateno H, Ushiku T, Ijichi H, Hirata Y, Kasuga M, Su GH, Wang TC, Fujishiro M. Arai J, et al. Among authors: murakami k. iScience. 2025 Jul 15;28(8):113117. doi: 10.1016/j.isci.2025.113117. eCollection 2025 Aug 15. iScience. 2025. PMID: 40761291 Free PMC article.
Metabolic reprogramming by PRDM16 drives cytarabine resistance in acute myeloid leukemia.
Ikeda J, Kunimoto H, Saito Y, Tsujimoto SI, Takeuchi M, Miura A, Kurosawa T, Murakami K, Kato I, Funakoshi-Tago M, Yokoyama A, Shiba N, Adachi S, Tomizawa D, Tamura T, Ito S, Nakajima H. Ikeda J, et al. Among authors: murakami k. Haematologica. 2025 Nov 1;110(11):2647-2660. doi: 10.3324/haematol.2024.287265. Epub 2025 Jun 12. Haematologica. 2025. PMID: 40501394 Free PMC article.
One-year follow-up of the immunogenicity and safety of a first and second booster dose of the NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Final report of a phase 3 open-label trial.
Kuriyama K, Murakami K, Sugiura K, Sakui S, Schuring RP, Mori M. Kuriyama K, et al. Among authors: murakami k. Vaccine. 2025 Aug 30;62:127562. doi: 10.1016/j.vaccine.2025.127562. Epub 2025 Aug 5. Vaccine. 2025. PMID: 40753673 Free article. Clinical Trial.
Tracking clusterin expression in hematopoietic stem cells reveals their heterogeneous composition across the life span.
Koide S, Oshima M, Kamiya T, Zheng Z, Liu Z, Rizq O, Nishiyama A, Murakami K, Yamada Y, Nakajima-Takagi Y, Rahmutulla B, Kaneda A, Yokoyama K, Yusa N, Imoto S, Miura F, Ito T, Tamura T, Nerlov C, Yamashita M, Iwama A. Koide S, et al. Among authors: murakami k. Blood. 2025 Jul 3;146(1):62-75. doi: 10.1182/blood.2024025776. Blood. 2025. PMID: 40132120
4,942 results